Educational Background

2019.09 - 2023.03: Ph.D. in Materials Science and Engineering, East China University of Science and Technology (ECUST)

2016.09 - 2019.06: M.Sc. in Inorganic Chemistry, Fuzhou University (FZU)

2011.09 - 2015.06: B.Sc. in Applied Chemistry, Science and Technology College of Nanchang Hangkong University (NCHU)

Professional Experience

2023.06 - Present: Lecturer, Jiangxi Science and Technology Normal University

Research Interests

1. Organic-inorganic hybrid biomaterials and their biomedical applications

2. Exogenous/endogenous stimuli-responsive nanocatalysts and their biomedical applications

Research Achievements

Dr. Li specializes in the design and biomedical applications of nanomaterials.

In recent years, as the project leader, Dr. Li has presided over the National Natural Science Foundation (Youth Program, Class C), Jiangxi Provincial Natural Science Foundation (Youth Program), and Ph.D. start-up funds of Jiangxi Science and Technology Normal University; As a key member of the project, participated in multiple scientific research projects such as the Shanghai Science and Technology Innovation Action Plan, the National Natural Science Foundation Key Research and Development Program and General Program, etc.

To date, Dr. Li has published over 20 peer-reviewed papers as the first author or corresponding author, with an H-index of 13. Dr. Li also serves as a Young Editorial Board Member for the journal Nano TransMed.

Selected Academic Monographs, Papers, and Patents

ORCID: https://orcid.org/0009-0003-9452-0620

1、 Xianglong Li, Cong Jiang, Qinghua Wang, Shaobo Yang, Yuanyuan Cao, Ji-Na Hao,* Dechao Niu, Yan Chen, Bo Han, Xin Jia, Peng Zhang,* and Yongsheng Li*, A “valve-closing” starvation strategy for amplification of tumor-specific chemotherapy, Advanced Science, 2022, 9, 2104671. (IF=14.3, First author)

2、 Xianglong Li, Cong Jiang, Xinlin Jia, Yuanyuan Cao, Yuanqing Mao, Ji-Na Hao,* Yang Yang, Peng Zhang,* and Yongsheng Li*, Dual “unlocking” strategy to overcome inefficient nanomedicine delivery and tumor hypoxia for enhanced photodynamic-immunotherapy, Advanced Healthcare Materials, 2023, 12, 2202467. (IF=10.0, First author)

3、 Cong Jiang, Xianglong Li,⁺ Shiyue Wan, Shuyu Ji, Qinghua Wang, Shiqi Hu, Pengcheng Chen, Bo Wang, Tao Ge, Jing Zhang, Yuanyuan Cao, Yang Yang,* Dapeng Zhang,* Yongsheng Li,* and Peng Zhang,* Copper‐doped polydopamine nanoparticles‐mediated GSH/GPX4‐depleted ferroptosis and cuproptosis sensitizes lung tumor to checkpoint blockade immunotherapy, Small 2025, 21, 2503208. (IF=13.0, Co-First author)

4、 Xionghongcan Zhou, Lihua Wang, Yayang Wu, Xiaoping Lin, Fen Liu, Xiaoxia Sun,* Kaiyue Song,* Cong Jiang,* Feng Zhao,* and Xianglong Li*, Bioactive polydopamine nanomedicines-assisted cancer immunotherapy, Materials Today Bio, 2025, 32, 101864. (IF=8.7, Corresponding author)

5、 Weihong Ding, Kaiyue Song,* Xianglong Li,* and Xiaoxia Sun*, High-temperature-stable RRAMs with well-defined thermal effect mechanisms enable by engineering of robust 2D <100>-oriented organic-inorganic hybrid perovskites, Chinese Chemical Letters, 2025, 36, 110495.(IF=9.4, Corresponding author)

6、 Kaiyue Song, Cong Jiang,* Shaorong Huang,* and Xianglong Li*, Exogenous/endogenous stimuli-responsive nanocatalysts trigger In Situ chemical reactions for tumor catalytic therapy: an up-to-date mini-review, Materials Chemistry Frontiers, 2025, 9, 189-203. (IF=6.0, Corresponding author)

7、 Heping Lin, Cong Jiang, Bo Wang, Yubin Wang, Zongxiao Shangguan, Youyi Wu, Xiaoyan Wang, Yiwei Huang, Lihua Wang, Pengcheng Chen, Xianglong Li,* Zhengrong Zhong,* and Songsong Wu*, Glutathione degradable manganese-doped polydopamine nanoparticles for photothermal therapy and cGAS-STING activated immunotherapy of lung tumor, Journal of Colloid and Interface Science, 2024, 663, 167-176. (IF=9.4, Corresponding author)

8、 Lihua Wang, Kaiyue Song,* Cong Jiang,* Shanping Liu, Shaorong Huang,* Huang Yang,* Xianglong Li,* and Feng Zhao*, Metal-coordinated polydopamine structures for tumor imaging and therapy, Advanced Healthcare Materials, 2024, 13, 2401451. (IF=10.0, Corresponding author)

9、 Cong Jiang,⁺ Xianglong Li,⁺ Fen Pan, Lele Zhang, Huansha Yu, Jing Zhang, Jinglin Zou, Tianyu Zhong, Dapeng Zhang, Yang Yang,* Yongsheng Li,* and Peng Zhang*, Ferroptosis and pyroptosis co-activated nanomodulator for “cold” tumor immunotherapy and lung metastasis inhibition, Advanced Functional Materials, 2023, 33, 2211698. (IF=18.5, Co-First author)

10、 Huan Wu,⁺ Xianglong Li,⁺ Shi Liu, Qinghua Wang, Yuanyuan Cao, Ji-Na Hao, and Yongsheng Li*, GSH-responsive organosilica hybrid nanosystem as a cascade promoter for enhanced starvation and chemodynamic therapy, Advanced Healthcare Materials, 2023, 12, 2201262. (IF=10.0, Co-First author)

11、 Jinglin Zou,⁺ Cong Jiang,⁺ Xianglong Li,⁺ Tianyu Zhong, Shuqi Wang, Bo Wang, Dapeng Zhang,* Ji-Na Hao, Yuanyuan Cao, Mengjia Guan, Peng Zhang,* Bin Dai, and Yongsheng Li*, Redox-responsive engineered hybrid nanomedicine for gallbladder cancer therapy via hyaluronic acid depletion, Applied Materials Today, 2023, 30, 101707. (IF=7.2, Co-First author)